JP2020531488A5 - - Google Patents

Download PDF

Info

Publication number
JP2020531488A5
JP2020531488A5 JP2020510114A JP2020510114A JP2020531488A5 JP 2020531488 A5 JP2020531488 A5 JP 2020531488A5 JP 2020510114 A JP2020510114 A JP 2020510114A JP 2020510114 A JP2020510114 A JP 2020510114A JP 2020531488 A5 JP2020531488 A5 JP 2020531488A5
Authority
JP
Japan
Prior art keywords
trifluoromethyl
pyridyl
alkyl
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020510114A
Other languages
English (en)
Japanese (ja)
Other versions
JP7201260B2 (ja
JP2020531488A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2018/072790 external-priority patent/WO2019038389A1/en
Publication of JP2020531488A publication Critical patent/JP2020531488A/ja
Publication of JP2020531488A5 publication Critical patent/JP2020531488A5/ja
Priority to JP2022199375A priority Critical patent/JP2023021316A/ja
Application granted granted Critical
Publication of JP7201260B2 publication Critical patent/JP7201260B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020510114A 2017-08-23 2018-08-23 ピリジンアミン-ピリドンおよびピリミジンアミン-ピリドン化合物 Active JP7201260B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022199375A JP2023021316A (ja) 2017-08-23 2022-12-14 ピリジンアミン-ピリドンおよびピリミジンアミン-ピリドン化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17187560.2 2017-08-23
EP17187560 2017-08-23
PCT/EP2018/072790 WO2019038389A1 (en) 2017-08-23 2018-08-23 PYRIDINAMINE-PYRIDONE AND PYRIMIDINAMINE-PYRIDONE COMPOUNDS

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022199375A Division JP2023021316A (ja) 2017-08-23 2022-12-14 ピリジンアミン-ピリドンおよびピリミジンアミン-ピリドン化合物

Publications (3)

Publication Number Publication Date
JP2020531488A JP2020531488A (ja) 2020-11-05
JP2020531488A5 true JP2020531488A5 (cg-RX-API-DMAC7.html) 2021-09-30
JP7201260B2 JP7201260B2 (ja) 2023-01-10

Family

ID=59686885

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020510114A Active JP7201260B2 (ja) 2017-08-23 2018-08-23 ピリジンアミン-ピリドンおよびピリミジンアミン-ピリドン化合物
JP2022199375A Ceased JP2023021316A (ja) 2017-08-23 2022-12-14 ピリジンアミン-ピリドンおよびピリミジンアミン-ピリドン化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022199375A Ceased JP2023021316A (ja) 2017-08-23 2022-12-14 ピリジンアミン-ピリドンおよびピリミジンアミン-ピリドン化合物

Country Status (21)

Country Link
US (2) US11208423B2 (cg-RX-API-DMAC7.html)
EP (2) EP3672948B1 (cg-RX-API-DMAC7.html)
JP (2) JP7201260B2 (cg-RX-API-DMAC7.html)
KR (1) KR102730753B1 (cg-RX-API-DMAC7.html)
CN (3) CN116041321A (cg-RX-API-DMAC7.html)
AU (2) AU2018320418B2 (cg-RX-API-DMAC7.html)
CY (1) CY1125728T1 (cg-RX-API-DMAC7.html)
DK (1) DK3672948T3 (cg-RX-API-DMAC7.html)
ES (1) ES2929424T3 (cg-RX-API-DMAC7.html)
FI (1) FI3672948T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20221454T1 (cg-RX-API-DMAC7.html)
HU (1) HUE060805T2 (cg-RX-API-DMAC7.html)
IL (3) IL292488B2 (cg-RX-API-DMAC7.html)
LT (1) LT3672948T (cg-RX-API-DMAC7.html)
PL (1) PL3672948T3 (cg-RX-API-DMAC7.html)
PT (1) PT3672948T (cg-RX-API-DMAC7.html)
RS (1) RS63795B1 (cg-RX-API-DMAC7.html)
SI (1) SI3672948T1 (cg-RX-API-DMAC7.html)
SM (1) SMT202200493T1 (cg-RX-API-DMAC7.html)
TW (2) TWI785102B (cg-RX-API-DMAC7.html)
WO (1) WO2019038389A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3672948T3 (pl) * 2017-08-23 2022-12-05 Sprint Bioscience Ab Związki pirydynoamino-pirydonu i pirymidynoamino-pirydonu
BR112020012651A2 (pt) 2017-12-22 2020-12-01 Ravenna Pharmaceuticals, Inc. compostos derivados de aril-bipiridina amina como inibidores da fosfatidilinositol fosfato quinase, composição farmacêutica compreendendo os mesmos e usos terapêuticos dos ditos compostos
AU2020398215A1 (en) * 2019-12-04 2022-06-16 Chdi Foundation, Inc. ATM kinase inhibitors and compositions and methods of use thereof
WO2022115558A1 (en) * 2020-11-25 2022-06-02 Deciphera Pharmaceuticals, Llc Morpholino derivatives as vsp34 inhibitors for use in the treatment of a viral infection
JP2023550638A (ja) 2020-11-25 2023-12-04 デシフェラ・ファーマシューティカルズ,エルエルシー ウイルス感染症の処置に使用するための、vsp34阻害剤としてのモルホリノ誘導体
WO2022115546A1 (en) 2020-11-25 2022-06-02 Deciphera Pharmaceuticals, Llc Anti-viral activity of vps34 inhibitors
EP4341254A4 (en) * 2021-05-20 2025-04-09 Dana-Farber Cancer Institute, Inc. INHIBITORS AND DEGRADERS OF THE PIP4K PROTEIN
CA3228766A1 (en) * 2021-08-13 2023-02-16 Yasmin YU Combination therapy of vps34 inhibitors and sting agonist for use in the treatment of cancer
AU2023255558A1 (en) * 2022-04-22 2024-10-31 Vertex Pharmaceuticals Incorporated Heteroaryl compounds for the treatment of pain
AU2024397820A1 (en) * 2023-12-13 2026-05-28 Deciphera Pharmaceuticals, Llc Vps34 inhibitors and methods of use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04011470A (es) * 2002-05-21 2005-02-14 Amgen Inc Compuestos heterociclicos sustituidos y metodos de uso.
EA201390917A1 (ru) * 2010-12-21 2013-12-30 Новартис Аг Дигетероарильные соединения в качестве ингибиторов vps34
PT2655375E (pt) 2010-12-23 2015-03-02 Sanofi Sa Derivados de pirimidinona, sua preparação e sua utilização farmacêutica
GB201120317D0 (en) 2011-11-24 2012-01-04 Queen Mary & Westfield College Screening method
FR2992314B1 (fr) 2012-06-22 2015-10-16 Sanofi Sa Nouveaux derives de 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one et 1,2,3,4-tetrahydro-pyrimido{1,2-a}pyrimidin-6-one comportant une morpholine substituee, leur preparation et leur utilisation pharmaceutique
WO2015108881A1 (en) 2014-01-14 2015-07-23 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
TN2016000270A1 (en) 2014-01-14 2017-10-06 Millennium Pharm Inc Heteroaryls and uses thereof.
MA39822A (fr) 2014-04-03 2018-02-06 Janssen Pharmaceutica Nv Dérivés de pyrimidine bicycle
MA39823A (fr) 2014-04-03 2018-01-09 Janssen Pharmaceutica Nv Dérivés de pyridine macrocyclique
WO2016001789A1 (en) 2014-06-30 2016-01-07 Pfizer Inc. Pyrimidine derivatives as pi3k inhibitors for use in the treatment of cancer
PL3416945T3 (pl) * 2016-02-19 2020-12-28 Sprint Bioscience Ab Związki 6-arylo-4-(morfolin-4-ylo)-1h-pirydyn-2-onu przydatne w leczeniu nowotworu i cukrzycy
PT3416957T (pt) 2016-02-19 2020-09-25 Sprint Bioscience Ab Compostos 6-heterociclil-4-morfolin-4-ilpiridin-2-ona úteis para o tratamento do cancro e da diabetes
PL3672948T3 (pl) * 2017-08-23 2022-12-05 Sprint Bioscience Ab Związki pirydynoamino-pirydonu i pirymidynoamino-pirydonu

Similar Documents

Publication Publication Date Title
HRP20221454T1 (hr) Piridinamin-piridonski i pirimidinamin-piridonski spojevi
JP2006509715A5 (cg-RX-API-DMAC7.html)
KR101985984B1 (ko) 키나아제 저해제로서의 벤조니트릴 유도체
RU2018131766A (ru) 6-гетероциклил-4-морфолин-4-илпиридин-2-оны, пригодные для лечения рака и диабета
JP2019505595A5 (cg-RX-API-DMAC7.html)
JP2012525395A5 (cg-RX-API-DMAC7.html)
JP2017502940A5 (cg-RX-API-DMAC7.html)
CA2605854A1 (en) Novel pyridine derivative and pyrimidine derivative (3)
JP2017525757A5 (cg-RX-API-DMAC7.html)
RU2015100942A (ru) Производное пиперидинилпиразолпиридина
JP2023021316A5 (cg-RX-API-DMAC7.html)
JP2002525358A5 (cg-RX-API-DMAC7.html)
RU2005108999A (ru) Азотсодержащие ароматические производные
RU2018131775A (ru) 6-арил-4-морфолин-1-илпиридоны, пригодные для лечения рака или диабета
RU2009104340A (ru) Производные [4,5']бипиримидинил-6,4'-диамина в качестве ингибиторов протеинкиназы
TW200526628A (en) Quinazoline derivatives
JP2019505594A5 (cg-RX-API-DMAC7.html)
RU2007106042A (ru) Замещенные биарильные аналоги пиперазинилпиридина
JP2017512184A5 (cg-RX-API-DMAC7.html)
JP2017536342A5 (cg-RX-API-DMAC7.html)
IL274198B2 (en) Use of Nox inhibitors to treat cancer
JP2020503302A5 (cg-RX-API-DMAC7.html)
JP2020531487A5 (cg-RX-API-DMAC7.html)
JP2020531485A5 (cg-RX-API-DMAC7.html)
JP2009537606A5 (cg-RX-API-DMAC7.html)